e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Lung development and neoplasia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Anti-fibrotic effects of liver X receptor agonists in human fetal lung fibroblasts
S. Hisata, S. Chiba, T. Ito, M. Ebina, T. Nukiwa (Sendai, Japan)
Source:
Annual Congress 2011 - Lung development and neoplasia
Session:
Lung development and neoplasia
Session type:
Thematic Poster Session
Number:
3804
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Hisata, S. Chiba, T. Ito, M. Ebina, T. Nukiwa (Sendai, Japan). Anti-fibrotic effects of liver X receptor agonists in human fetal lung fibroblasts. Eur Respir J 2011; 38: Suppl. 55, 3804
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Naftopidil, a selective a1 adrenoceptor antagonist, inhibits the growth of lung fibroblasts and attenuates bleomycin-induced lung fibrosis in mice
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017
Muscarinic receptors mediate up-regulation of endothelin-1 expression in human lung fibroblasts
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
Modulation of bleomycin-induced lung fibrosis by serotonin receptor antagonists in mice
Source: Eur Respir J 2008; 32: 426-436
Year: 2008
IL-13Rα2 is necessary for
in vitro
anti-proliferative activity of CXCR3 ligands in mouse lung fibroblasts
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
The effects of human lung mast cell products on the synthetic functions of lung fibroblasts
Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung
Year: 2012
Differential effects of pharmacological leukotriene pathway modulators in a human lung tissue explant model
Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms
Year: 2020
Hypoxia-mediated alterations in adenosine receptor expression in rat lung
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011
Synergistic action of formoterol on budesonide-generated decrease of proteoglycan production by activated lung fibroblasts is mediated via β-adrenergic receptor and is dependent on glucocorticoid receptor
Source: Eur Respir J 2004; 24: Suppl. 48, 345s
Year: 2004
The nuclear liver X receptor and its role in smoke exposed rat lungs
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011
Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts
Source: Eur Respir J 2008; 32: 555-562
Year: 2008
HDAC2-independent anti-inflammatory effects of budesonide in human lung fibroblasts
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011
The expression of muscarinic receptors is involved in the p42/44ERK and NF-kB activation of human lung fibroblasts from COPD subjects
Source: Eur Respir J 2006; 28: Suppl. 50, 102s
Year: 2006
Expression and functional involvement of muscarinic receptor 3 (M3) in human lung fibroblasts in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 121s
Year: 2005
Effects of Liver X receptor agonist treatment on signal transduction pathways in acute lung inflammation
Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis
Year: 2010
Chemokine receptor expression by human lung mast cells
Source: Annual Congress 2003 - Cell signalling and cytokines in asthma
Year: 2003
Glucocorticoid receptor expression in different rat models of acute lung injury
Source: Eur Respir J 2004; 24: Suppl. 48, 104s
Year: 2004
Glycosphingolipids modulate TGF-β fibrotic signaling in human lung fibroblasts
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011
Mechanisms of bradykinin-induced contraction in human fetal lung fibroblasts
Source: Eur Respir J 2010; 36: 655-664
Year: 2010
Anti-inflammatory effects of roflumilast N-oxide and dexamethasone in human bronchial epithelial cells stimulated with toll-like receptor agonists
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013
Anti-inflammatory efficacy of formoterol via transrepressive mechanisms is independent of the glucocorticoid receptor in human bronchial epithelial cells
Source: Eur Respir J 2004; 24: Suppl. 48, 128s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept